1015 Walnut Street
Suite 409
Philadelphia, PA 19107
(215) 955-3900
(215) 923-3836 fax
Suite 409
Philadelphia, PA 19107
(215) 955-3900
(215) 923-3836 fax
Most Recent Peer-reviewed Publications
- Monocytes in HIT: An evolving story
- CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
- Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
- PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
- Amelioration of murine immune thrombocytopenia by CD44 antibodies: A potential therapy for ITP?
Research and Clinical Interests
Dr. McKenzie directs two major research projects. The first project involves vascular biology, with a focus on immune-mediated thrombocytopenia and thrombosis syndromes. This work, done in collaboration with Dr. Michael Reilly, led to the first model of heparin-induced thrombocytopenia and thrombosis. New work on effects of elevated cholesterol and athrosclerosis on HITT, and on microparticles and tissue factor, is ongoing.
